- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about IXHL
Recent news which mentions IXHL
From Benzinga
Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
March 03, 2023
From Benzinga
Incannex Starts Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
February 28, 2023
Tickers
IXHL
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 25, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 25, 2023
From Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 25, 2023
From Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
January 18, 2023
Tickers
IXHL
From Benzinga
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
December 13, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 08, 2022
From Benzinga
From InvestorPlace
Incannex Files A Provisional Patent Application Of Its THC-Based IHL-42X For The Treatment Of Obstructive Sleep Apnea
December 06, 2022
Tickers
IXHL
From Benzinga
Eurofins To Produce Incannex' 2 CBD Medicated Chews For Treatment Of Nicotine And Opioid Addiction Disorders
November 28, 2022
From Benzinga
Incannex Initiates BA/BE Clinical Trial Evaluating IHL-42X In Obstructive Sleep Apnoea
November 17, 2022
Tickers
IXHL
From Benzinga
A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond
November 09, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 04, 2022
From Benzinga
Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders
October 28, 2022
Tickers
IXHL
From Benzinga
From InvestorPlace
Unrivaled Brands & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About
August 19, 2022
From Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
August 17, 2022
From Benzinga
From Benzinga
From Benzinga
Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug
July 21, 2022
Tickers
IXHL
From Benzinga
Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea
June 03, 2022
Tickers
IXHL
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 31, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 30, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 29, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.